Kabra Drugs Financials

BSE: 524322

₹20.75

₹0.06 (0.29%)

As on 09-Sep-2026 14:12IST

Market cap

₹49 Cr

Revenue (TTM)

₹132 Cr

P/E Ratio

6.5

P/B Ratio

1.6

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Operating Revenue	131.81	--	--	--	--	--
Total Income	132.36	0.64	--	0.01	--	--
Total Expenditure	123.21	1.72	0.74	0.34	0.18	0.15
EBITDA	8.60	-1.72	-0.74	-0.34	-0.18	-0.15
Depreciation	0.06	0.01	--	--	0.01	0.03
EBIT	8.53	-1.72	-0.74	-0.34	-0.19	-0.18
Interest	0.02	0.00	0.00	0.00	0.00	--
Other Income	0.55	0.64	--	0.01	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	9.07	-1.09	-0.74	-0.34	-0.19	-0.18
Provision for Tax	1.48	0.00	--	--	--	--
Profit after Tax	7.59	-1.09	-0.74	-0.34	-0.19	-0.18

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Shareholder's Funds	29.62	24.65	1.08	-0.73	-0.39	-0.21
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.12	0.00	--	--	--	--
Current Liabilities	56.54	0.57	3.49	1.43	1.12	1.61
Total Liabilities	86.27	25.23	4.57	0.70	0.73	1.40

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Non-Current Assets	2.18	0.07	0.02	0.02	0.02	0.03
Current Assets	83.92	25.16	4.55	0.68	0.71	1.37
Total Assets	86.27	25.23	4.57	0.70	0.73	1.40
Total Debt*	--	0.44	1.71	1.38	1.03	0.90
Net Current Assets	27.38	24.59	1.06	-0.75	-0.42	-0.24
Contingent Liabilities	--	0.49	0.48	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Cash From Operating Activities	--	-4.71	-0.21	-0.35	-0.13	-0.25
Cash Flow from Investing Activities	--	-0.05	--	--	--	--
Cash from Financing Activities	--	23.39	2.88	0.36	0.13	0.25
Net Cash Inflow / Outflow	--	18.63	2.67	0.00	-0.01	0.00

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Adjusted EPS (₹)	3.20	-0.46	-1.68	-0.77	-0.42	-0.41
Cash EPS (₹)	3.20	-0.45	-1.68	-0.77	-0.40	-0.34
Adjusted Book Value (₹)	13.39	10.40	-3.34	-1.67	-0.90	-0.47
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-1.99	-0.48	-0.81	-0.30	-0.57
Free Cash Flow per Share (₹)	--	-2.01	-0.48	-0.81	-0.30	-0.57

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
ROCE (%)	--	-7.78	-42.74	-52.60	-27.96	-27.33
ROE (%)	27.30	-9.36	--	--	--	--
ROA (%)	13.61	-7.29	-27.91	-47.15	-17.39	-12.78
EBIT Margin (%)	6.47	--	--	--	--	--
Net Margin (%)	5.73	-169.57	--	-5,299.23	--	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Revenue Growth (%)	821.73	--	--	--	--	--
EBIT Growth (%)	608.88	-134.41	-113.86	-85.64	-2.92	-122.26
Net Profit Growth (%)	855.12	-47.48	-117.85	-82.26	-2.98	-202.11
EPS Growth (%)	441.96	72.70	-117.83	-82.29	-2.97	-202.06
Book Value Growth (%)	--	1,780.51	-100.69	-85.95	-89.24	-649.48

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Price / Earnings	6.50	--	--	--	--	--
Price / Book Value	1.55	1.07	-2.15	-3.34	-5.08	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	4.33	-5.02	-2.98	-11.33	-17.23	-35.49
Close Price (₹)	22.99	11.08	7.19	5.57	4.55	--
High Price (₹)	35.52	11.08	7.19	5.70	5.98	--
Low Price (₹)	15.50	7.19	3.18	2.95	3.62	--
Market Cap (₹ Cr)	49.31	--	--	--	--	--

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debt to Equity	--	0.02	-1.16	-1.89	-2.61	-4.33
Short term debt to equity ratio	--	0.02	1.58	-1.89	-2.61	-4.33
Current Ratio	1.48	43.84	1.30	0.47	0.63	0.85
Quick Ratio	1.48	43.84	1.30	0.47	0.63	0.85
Interest Coverage	413.05	-1,084.10	-1,471.20	-1,088.65	-1,698.31	--

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debtors to sales (%)	53.70	--	--	--	--	--
Asset Turnover	2.36	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)